InsiderTrades

Form 4 for ALMS ALUMIS INC.

Accepted 2024-07-01 00:00:00 ET · period of report 2024-07-01 · accession 0001415889-24-018603 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2024-07-01 2024-07-01 ALMS AKKARAJU SRINIVAS Dir C - Cnv Deriv — +1.70M 1.70M New —
DI 2024-07-01 2024-07-01 ALMS AKKARAJU SRINIVAS Dir A - Grant — +1.70M 1.70M New —
DI 2024-07-01 2024-07-01 ALMS AKKARAJU SRINIVAS Dir D - Sale to Iss — -1.70M 0 -100% —
DI 2024-07-01 2024-07-01 ALMS AKKARAJU SRINIVAS Dir C - Cnv Deriv $0.00 -1.70M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-07-01 C A 1,703,998 — 1,703,998 I By Samsara BioCapital, L.P. — — (F1) Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the "Preferred Stock") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date. (F2) Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.
2 Common Common Stock 2024-07-01 A A 1,703,998 — 1,703,998 I By Samsara BioCapital, L.P. — — (F3) Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock. (F2) Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.
3 Common Class A Common Stock 2024-07-01 D D 1,703,998 — 0 I By Samsara BioCapital, L.P. — — (F3) Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock. (F2) Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.
4 Derivative Series C Preferred Stock 2024-07-01 C D 1,703,998 $0.00 0 I By Samsara BioCapital, L.P. — · — to — 1,703,998 Class A Common Stock (F2) Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. (F1) Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the "Preferred Stock") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date.